Serum unsaturated phosphatidylcholines predict longitudinal basal forebrain degeneration in Alzheimer’s disease is a research paper published in Brain Communications (2022). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U01 AG024904
Department of Defense
Grant: W81XWH-12-2-0012
National Institute on Aging
Grant: R01AG046171
National Institute on Aging
Grant: RF1AG051550
National Institute on Aging
Grant: 3U01AG024904-09S4
ADNI Duke Supplement
National Institutes of Health
Grant: U2CES026561
National Institutes of Health
Grant: U2CES026555
National Institutes of Health
Grant: P30ES023515
National Institutes of Health
Grant: U2CES030859
National Institutes of Health
Grant: UL1TR001433
Canada Institutes of Health Research
Grant: PJT 175328
Alzheimer’s Society of Canada
Grant: 176677
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 3U2CES026561-01S2
Mount Sinai CHEAR Network Laboratory Hub
National Institutes of Health
Grant: 5U2CES030859-03
Mount Sinai HHEAR Network Untargeted Lab Hub
National Institutes of Health
Grant: 3U2CES026555-01S1
CHEAR Center for Data Science
National Institutes of Health
Grant: 2P30ES023515-05
The Mount Sinai Transdisciplinary Center on Early Environmental Exposures
National Institutes of Health
Grant: 5R01AG046171-03
Metabolic Networks and Pathways in Alzheimer's Disease
National Institutes of Health
Grant: 5UL1TR001433-02
MSHS Translational Science Hub
National Institutes of Health
Grant: 3RF1AG051550-01S1
Metabolic Signatures Underlying Vascular Risk Factors for Alzheimer-type Dementias
Biogen
Fujirebio
IXICO Ltd
Merck & Co., Inc.
National Institute on Aging
Transition Therapeutics
Alzheimer's Therapeutic Research Institute at the University of Southern California
Canada Graduate Scholarship
Elan Pharmaceuticals, Inc.
Bristol-Myers Squibb Company
NeuroRx Research
Neurotrack Technologies
Northern California Institute for Research and Education
Piramal Imaging
ADNI
Alzheimer's Drug Discovery Foundation
Alzheimer’s Disease Neuroimaging Initiative
Araclon Biotech
CereSpir, Inc.
Foundation for the National Institutes of Health
Lumosity; Lundbeck
Takeda Pharmaceutical Company
Eisai Inc.
Meso Scale Diagnostics, LLC
Cogstate
Janssen Alzheimer Immunotherapy Research & Development, LLC
Johnson & Johnson Pharmaceutical Research & Development LLC
Servier
The Canadian Institutes of Health Research
Alzheimer Society of London and Middlesex
Alzheimer's Association
Alzheimer's Disease Metabolomics Consortium
Eli Lilly and Company
Genentech, Inc.
HRCS
Laboratory for Neuro Imaging at the University of Southern California
Novartis Pharmaceuticals Corporation
BioClinica, Inc.
EuroImmun
F. Hoffmann-La Roche Ltd
GE Healthcare
National Institute of Biomedical Imaging and Bioengineering
Pfizer Inc.
FWCI
1.43
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals